X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

期刊標題檢索 EUR J CLIN PHAR 最新評論: Yes, I submitted to the OA, it's faster, and usually takes around 3 m... (2024-06-05)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY]您好,您是該頁面的第 28098 位訪客。

期刊簡介
期刊名稱EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
LetPub Score
6.6
50 ratings
Rate

Reputation
7.5

Influence
5.1

Speed
9.5

期刊簡稱EUR J CLIN PHARMACOL
ISSN0031-6970
E-ISSN1432-1041
h-index99
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.400.7270.990
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q292 / 272
Category: Medicine
Subcategory: Pharmacology
Q2142 / 313

自引率 (2023-2024)4.20%自引率趨勢
掲載範囲
The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans. Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs. Methodological contributions relevant to these topics are also welcomed.

Data from animal experiments are accepted only in the context of original data in man reported in the same paper. EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants. Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor.

Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves

-a compound that is interesting and new in some basic or fundamental way, or
-methods that are original in some basic sense, or
-a highly unexpected outcome, or
-conclusions that are scientifically novel in some basic or fundamental sense.
官方網站https://www.springer.com/228
在線稿件提交https://www.editorialmanager.com/ejcl
開放訪問No
出版商Springer Berlin Heidelberg
主題領域医学
出版國/地區GERMANY
發行頻率月刊
創刊年1968
每年文章數153每年文章數趨勢
黃金OA百分比32.62%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ3188/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0031-6970%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498338
    PHYTOMEDICINE340366
    LIFE SCIENCES285849
    International Journal of Pharmaceutics242444
    PHARMACOLOGICAL RESEARCH241359
    European Journal of Pharmacology204251
    BIOCHEMICAL PHARMACOLOGY202704
    JOURNAL OF NATURAL PRODUCTS196697
    BRITISH JOURNAL OF PHARMACOLOGY165150
    MOLECULAR PHARMACEUTICS162838
  •  

    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY] 的評論撰寫評論
作者: jiangluer


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-06-05 23:41:32 評論於
Yes, I submitted to the OA, it's faster, and usually takes around 3 months for acceptance and 4 months to publication
(0) 讚! | jiangluer

作者: camellial


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-31 15:32:13 評論於
Is the traditional publishing model free of charge, how long does the review process typically take, and how long until publication?
(0) 讚! | camellial

作者: jiangluer


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2023-10-31 17:12:41 評論於
Relatively easy to accept, innovative points are fairly easy, and the editor is easy to talk to. After major revisions, the review process is a bit slow, the journal takes a long time to find reviewers, and the APC processing fee is too expensive, over 4000 dollars
(0) 讚! | jiangluer

作者: 是亚飞吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-17 09:49:30 評論於
Does this journal have an impact factor? I confused it with the European Journal of Pharmacology when I checked. Someone told me that it does not have an impact factor, so it does not count as an SCI article, and the article processing fee cannot be reimbursed
(0) 讚! | 是亚飞吖

作者: 北国半蕾


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-19 15:58:54 評論於
Do you need to pay for layout fee?
(0) 讚! | 北国半蕾

作者: 玉萧如白


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-03 17:48:46 評論於
Do you have any experience of changing the corresponding author after acceptance?
(0) 讚! | 玉萧如白

作者: 玉萧如白


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-03 09:02:02 評論於
Do you have any experience of changing the corresponding author after acceptance?
(0) 讚! | 玉萧如白

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:19:47 評論於
Almost all freely submitted academic papers that meet the publication requirements after review need to be returned to the authors for revisions before publication. This may involve editing the expression and formatting, such as compressing the length of the paper, redesigning tables, improving the quality of illustrations, and restricting the use of irregular abbreviations. However, returning the manuscript to the authors for revisions does not mean that the article has been accepted. The final acceptance of the article depends on whether the author's modifications to the key elements and expression of the article meet the requirements of the reviewers and editors.

The materials usually returned to the authors for revisions include the original manuscript, reviewers' comments, and a cover letter from the editor. When authors receive the revised manuscript, they should carefully read the cover letter and reviewers' comments. They should then consider whether they can or are willing to accept the reviewers' or editor's suggestions and make revisions. The likelihood of the article being accepted can be seen from the responses of the chief editor and reviewers to the revised manuscript. Revisions should not be rushed, and authors should carefully read and understand the reviewers' questions. They should respond to each reviewer's comments individually and specifically indicate the modifications made in the revised manuscript (page, lines). In the response to the chief editor, authors should express gratitude for the suggested revisions and explain reasons for areas where modifications were not made
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:21:42 評論於
Submission completed - Formatting review - Initial editor review - Peer review - Review completed - Final editor review - Author revisions
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 14:24:47 評論於
What is the process of a refund?
(0) 讚! | 陶宜三岁啦

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 11:38:42 評論於
What is the process for peer review?
(0) 讚! | Oswald Edie

作者: Zsf123


領域: 医学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-15 09:35:51 評論於
May I ask, it has been over two months since I submitted. The submission interface still shows "Reviewers Assigned." What does this status mean? Do I have to wait for the "under review" stage?
(0) 讚! | Zsf123

作者: 天山孤萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-22 13:49:45 評論於
Review speed: 6.0 | Submission acceptance rate: 25.0 
Experience sharing: The first SCI clinical article in my life was submitted on November 10, 2019. During the process, I encountered opinions from 2 reviewers that could not be determined, so a third arbitration was added. Major revisions were made on February 1, 2020, addressing 17 major issues and providing a 14-page response. Minor revisions were made during the second review, and the article was finally accepted on May 20. It is worth commemorating
(0) 讚! | 天山孤萍

作者: 潜龙乐易


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-13 11:30:07 評論於
Interested in receiving articles on the pharmacology of traditional Chinese medicine?
Chelsey 2020-03-10 09:11:00 Published: Journal Name: European Journal of Clinical Pharmacology Field: Clinical Pharmacology Country: Sweden Submission Date: 2019-12-18 Submission Method (online submission system or postal submission, please provide submission link if online): https://www.springer.com/journal/228 Revised Date: 2020-01-23 Revision Method (major revision, minor revision, rejection): Major revision once Acceptance Date: 2020-02-26 Does it charge page fees: No Sharing Experience or Lessons: Both review and publication efficiency are very high
(0) 讚! | 潜龙乐易

作者: 傲寒问蕊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-05-04 18:25:50 評論於
Haha, it's really fate... Brother die
(0) 讚! | 傲寒问蕊

作者: Nora Bertha


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-24 19:45:16 評論於
Can clinical trial articles be received?
(0) 讚! | Nora Bertha

作者: 羽蒙


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2020-03-17 17:31:07 評論於
Editors of this journal preferred the research with clinical patient data. However, the processing efficiency was high! It took about one month for external review.

(2) 讚! | 羽蒙

作者: 平原啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-17 16:33:04 評論於
Review speed: 1.0 Experience sharing: The journal prefers research with clinical patient data aspects, but the efficiency is high! External review takes about a month
(0) 讚! | 平原啸天

作者: 长安歆艺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-10 18:17:06 評論於
Review speed: 1.0 | Submission acceptance rate: 75.0
Experience sharing: Journal Name: European Journal of Clinical Pharmacology
Field of expertise: Clinical Pharmacology
Journal country: Sweden
Submission date: 2019-12-18
Submission method (submission system or mail, if there is a submission system, please provide the submission link): https://www.springer.com/journal/228
Revision date: 2020-01-23
Mode of revision (major revision, minor revision, rejection): major revision once
Acceptance date: 2020-02-26
Whether there is a page charge: No
Experience sharing or lessons: Both the review and publication efficiency are very high
(0) 讚! | 长安歆艺

作者: 长安歆艺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-10 14:30:36 評論於
Review speed: 1.0 | Submission success rate: 75.0
Experience sharing: Journal Name: European Journal of Clinical Pharmacology
Area of expertise: Clinical Pharmacology
Journal Country: Sweden
Submission Date: 2019-12-18
Submission method (submission system or mailing, if there is a submission system, please provide the submission link): https://www.springer.com/journal/228
Revision Date: 2020-01-23
Way of revision (major revision, minor revision, rejection): Major revision once
Acceptance Date: 2020-02-26
Is there a page fee: No
Shared experience or lessons: The review and publication efficiency are very high
(0) 讚! | 长安歆艺

作者: 长安歆艺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-10 14:21:03 評論於
Review speed: 1.0 | Submission hit rate: 75.0
Experience sharing: Journal name: European Journal of Clinical Pharmacology
Specialty: Clinical Pharmacology
Journal country: Sweden
Submission date: 2019-12-18
Submission method (submission system or mail, please provide submission link if there is a submission system):  https://www.springer.com/journal/228  https://www.editorialmanager.com/ejcl
Revision date: 2020-01-23
Revision method (major revision, minor revision, rejection): Major revision once
Acceptance date: 2020-02-26
Is there a page fee: No
Sharing experience or lessons learned: Phase I PK/PD research, tragically did not receive under review when submitted to other journals before, submitted to EJCP and received quick feedback, very efficient review and publication process
(0) 讚! | 长安歆艺

作者: 长安歆艺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-09 11:16:03 評論於
Review speed: 1.0 | Submission hit rate: 75.0
Experience sharing: Journal name: European Journal of Clinical Pharmacology
Field of expertise: Clinical pharmacology
Journal country: Sweden
Submission date: 2019-12-18
Submission method (submission system or by mail, if there is a submission system, please provide the submission link):
https://www.springer.com/journal/228
https://www.editorialmanager.com/ejcl
Revision date: 2020-01-23
Revision method (major revision, minor revision, rejection): Major revision once
Acceptance date: 2020-02-26
Is there a page fee: No
Sharing of experience or lessons learned: I Phase I PK/PD study, previously submitted to other journals without under review, tragic, submitted to EJCP, feedback was very quick, review and publication efficiency very high
(0) 讚! | 长安歆艺

作者: 辉夜碧秋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-01-30 11:02:37 評論於
When did you submit that meta? I want to submit mine too
(0) 讚! | 辉夜碧秋

作者: 韦陀灵萱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-05-25 17:01:57 評論於
My first SCI paper, gratitude for the acceptance back then, in a reputable journal, with an impact factor of 2.98, a meta-study
(0) 讚! | 韦陀灵萱

作者: 水蓝色


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2018-04-06 11:28:02 評論於
Hired after two major repairs.Each month 1
(0) 讚! | 水蓝色

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*